Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.770
+0.140 (8.59%)
At close: May 12, 2025, 4:00 PM
1.800
+0.030 (1.69%)
After-hours: May 12, 2025, 7:33 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $66.50 million as of May 12, 2025. Its market cap has decreased by -82.79% in one year.
Market Cap
66.50M
Enterprise Value
38.57M
1-Year Change
-82.79%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $66.50M, a decrease of -86.40%. That is a compound annual growth rate of -38.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 61.24M | -56.44% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.26B |
| Johnson & Johnson | 372.03B |
| UnitedHealth Group | 342.63B |
| AbbVie | 337.49B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.63B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |